IP Verse

Crystalline Solid Forms Of 6-Carboxy-2-(3,5-Dichlorophenyl)-Benzoxazole

PatentPatent Analysis

EP3191461

PFIZER
Application Number
EP15771276A
Filing Date
Aug 31, 2015
Status
Granted And Under Opposition
Oct 1, 2021
Grant Date
Nov 3, 2021
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3781132B1
EP3977993B1
EP3583947B1

Bibliography

The patent EP3191461B1 was granted to Pfizer on Nov 3, 2021 following the initial filing on Aug 31, 2015 under the application number EP15771276A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ALFRED E TIEFENBACHERAug 3, 2022ADMISSIBLE
GALENICUM HEALTH SLUAug 3, 2022ADMISSIBLE
HOLLATZAug 3, 2022ADMISSIBLE
KELTIEAug 3, 2022ADMISSIBLE
QUIMICA SINTETICAAug 3, 2022ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents